Dr. Samuel Olsen, MD (he/him) is a Sports Medicine Doctor, Internist in Etowah, TN with over 18 years of experience. What is your opinion of Dr. Samuel Olsen, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Samuel Olsen, MD has received over $12,439 which includes payments from the following companies:
$1,617.73 from Novo Nordisk Inc
$1,486.43 from AstraZeneca Pharmaceuticals LP
$1,140.58 from Amgen Inc.
$964.44 from sanofi-aventis U.S. LLC
$776.72 from Pfizer Inc.
$773.44 from Boehringer Ingelheim Pharmaceuticals, Inc.
$730.87 from Takeda Pharmaceuticals America, Inc.
$686.26 from LILLY USA, LLC
$520.62 from Janssen Pharmaceuticals, Inc
$518.16 from Novartis Pharmaceuticals Corporation
$437.29 from Regeneron Healthcare Solutions, Inc.
$382.58 from Merck Sharp & Dohme Corporation
$373.94 from GlaxoSmithKline, LLC.
$228.80 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$206.39 from Amarin Pharma Inc.
$198.95 from Allergan Inc.
$162.44 from Takeda Pharmaceuticals U.S.A., Inc.
$143.11 from Actavis Pharma Inc
$98.72 from Ironwood Pharmaceuticals, Inc
$98.40 from Daiichi Sankyo Inc.
Payments received by Dr. Samuel Olsen, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!